Cosmos Health Inc. (NASDAQ:COSM) Sees Significant Drop in Short Interest

Cosmos Health Inc. (NASDAQ:COSMGet Free Report) was the target of a significant drop in short interest in July. As of July 15th, there was short interest totalling 284,100 shares, a drop of 62.7% from the June 30th total of 761,500 shares. Approximately 1.9% of the company’s stock are sold short. Based on an average daily volume of 1,990,000 shares, the short-interest ratio is currently 0.1 days.

Institutional Investors Weigh In On Cosmos Health

An institutional investor recently bought a new position in Cosmos Health stock. Armistice Capital LLC bought a new position in Cosmos Health Inc. (NASDAQ:COSMFree Report) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund bought 1,334,937 shares of the company’s stock, valued at approximately $1,882,000. Armistice Capital LLC owned 7.89% of Cosmos Health at the end of the most recent quarter. Hedge funds and other institutional investors own 12.61% of the company’s stock.

Cosmos Health Price Performance

Shares of COSM traded up $0.07 on Thursday, hitting $1.28. 1,638,363 shares of the stock traded hands, compared to its average volume of 1,063,693. The business has a 50 day simple moving average of $0.87 and a 200 day simple moving average of $0.83. Cosmos Health has a one year low of $0.47 and a one year high of $2.05.

Cosmos Health Company Profile

(Get Free Report)

Cosmos Health Inc provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies.

Read More

Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.